EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC 4.0

Genotype Versus Phenotype in Pandrug-Resistant Pseudomonas aeruginosa : Key Considerations for Interpretation

Tarun Kumar Suvvari iD, Venkataramana Kandi, Sridhar Vns Kocharlakota

Clinical Medicine Insights: Case Reports · 2026-05 · 19

DOI: 10.1177/11795476261457672 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical Medicine Insights: Case Reports, online erschienen am 28.05.2026. Verfasst von Tarun Kumar Suvvari und 2 weiteren Autor:innen. Beteiligte Einrichtung: Rangaraya Medical College, Kakinada, India. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Rangaraya Medical College, Kakinada, India.
  • Infectious Diseases Research Group, Squad Medicine and Research (SMR), Amadalavalasa, India.
  • Department of Microbiology, Prathima InCte of Medical Sciences, Karimnagar, India.
  • Government Medical College, Srikakulam, Andhra Pradesh, India.

ORCID-Profile: Tarun Kumar Suvvari

Zitieren

APA

Suvvari, T. K., Kandi, V., & Kocharlakota, S. V. (2026). Genotype Versus Phenotype in Pandrug-Resistant Pseudomonas aeruginosa : Key Considerations for Interpretation. Clinical Medicine Insights: Case Reports, 19. https://doi.org/10.1177/11795476261457672

Vancouver

Suvvari TK, Kandi V, Kocharlakota SV. Genotype Versus Phenotype in Pandrug-Resistant Pseudomonas aeruginosa : Key Considerations for Interpretation. Clinical Medicine Insights: Case Reports. 2026;19. doi:10.1177/11795476261457672

BibTeX
@article{Suvvari2026,
  author = {Suvvari, Tarun Kumar and Kandi, Venkataramana and Kocharlakota, Sridhar Vns},
  title = {Genotype Versus Phenotype in Pandrug-Resistant Pseudomonas aeruginosa : Key Considerations for Interpretation},
  journal = {Clinical Medicine Insights: Case Reports},
  year = {2026},
  volume = {19},
  doi = {10.1177/11795476261457672}
}
Kostenlos starten →